Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team ...

Researchers used CAR T therapy to target beta amyloid plaques in Alzheimer’s disease. In mice, the modified immune cells ...

Researchers at Niigata University used advanced three-dimensional imaging to reveal how amyloid β deposits spread along blood ...

Studies reveal the therapeutic mechanism of action for levetiracetam to prevent the production of Aβ and, consequently, downstream irreversible damage.

By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the ...

Is the IDOL enzyme the key to stopping Alzheimer's? New research shows that blocking this single target can dissolve brain plaques and boost cognitive resilience.

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...

Scientists identify a neuronal enzyme linked to amyloid plaque formation, opening new possibilities for targeted Alzheimer’s disease treatment.

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...

The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

Researchers at Niigata University have used advanced three-dimensional (3D) imaging to reveal how amyloid β (Aβ) deposits spread along blood vessels in the human brain in cerebral amyloid angiopathy ...